Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

• Status: Completed
• Trial end date: 2000-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Etoricoxib

Criteria

Inclusion Criteria:

• Low back pain for previous 3 months and majority of days in last month

• Regular use of acetaminophen or NSAID to treat low back pain in past month

• Judged to be in otherwise good health

Exclusion Criteria:

• Low back pain that is due to secondary causes

• Radicular/myelopathic pain

• Surgery for low back pain within the past 6 months

• Active lawsuit or claim pertaining to their low back pain

• Disease that may confound the results of the study or pose risk to the patients

• Corticosteroid use in past month

• Previous participation in MK0663 study